Diagnostic News and Research

RSS

FDA approves Boston Scientific's Renegade HI-FLO Fathom Pre-Loaded System

Boston Scientific Corporation today announced that the U.S. Food and Drug Administration has approved its Renegade HI-FLO Fathom Pre-Loaded System for selective access and delivery of diagnostic, embolic and therapeutic materials into the peripheral vasculature.

1 Feb 2011

Radia announces diagnostic imaging services partnership with Jefferson Healthcare

Radia, is proud to announce a diagnostic imaging services partnership with Jefferson Healthcare commencing on January 1, 2011. Jefferson Healthcare, located in Port Townsend, WA, is a comprehensive healthcare center providing services for the more than 29,500 residents of Jefferson County.

31 Jan 2011

Loyola inaugurates clinic exclusively to treat children with headaches

Fortunately, in most cases the causes of childhood headaches are usually no cause for alarm, Schnitzler said. Children can get headaches from stress, anxiety, inadequate sleep, vision problems, caffeine or food sensitivities. To help pinpoint the cause, Loyola has opened a clinic that's exclusively devoted to treating children with headaches.

31 Jan 2011

Research findings could help psychiatrists better diagnose depression, schizophrenia

When elderly drivers get behind the wheel, they often confront the harrowing reality that they cannot easily see other cars, pedestrians, or cyclists moving around them. This frightening effect of aging, it turns out, is not necessarily a result of a reduced ability to perceive moving objects, as one might suspect, but a heightened awareness of the backdrop against which these objects move.

29 Jan 2011

GE Capital provides capital to XDx to help increase commercialization of AlloMap molecular diagnostic test

GE Capital, Healthcare Financial Services announced today that it has provided, as sole lender, a $12.5 million senior secured multi-draw term loan facility to XDx, Inc. The financing provides XDx with working capital to expand the commercialization of its FDA-cleared, innovative, noninvasive AlloMap molecular diagnostic test and pursue the development of other gene expression-based tests for autoimmune diseases including lupus.

29 Jan 2011

FDA reports possible association between breast implants, ALCL

The U.S. Food and Drug Administration reported on January 26 that "a possible association between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma, a very rare type of cancer. Data reviewed by the FDA suggests that patients with breast implants may have a very small, but significant risk, of ALCL in the scar capsule adjacent to the implant.

29 Jan 2011

Disparities in limb salvage procedures may be driven by SES, access to high-volume hospitals

Researchers from Brigham and Women's Hospital at Harvard Medical School in Boston, MA have published a study in the February Journal of Vascular Surgery stating that disparities in limb salvage procedures may be driven by socioeconomic status and access to high-volume hospitals.

29 Jan 2011

New research shows CEUS can improve diagnosis of variety of medical conditions in children

New research released here Thursday shows that "contrast-enhanced ultrasound" can safely improve the diagnosis of a variety of medical conditions in children - without exposing them to ionizing radiation.

29 Jan 2011

XDx establishes $12.5 million multi-draw term loan facility with GE Capital

XDx, a San Francisco-based molecular diagnostics company focused on non-invasive gene expression-based tests for the monitoring of organ transplant rejection and autoimmune diseases, announced today that it has established a $12.5 million senior secured multi-draw term loan facility with GE Capital, Healthcare Financial Services.

28 Jan 2011

IDEXX Laboratories fourth quarter revenues increase 5% to $283.8 million

IDEXX Laboratories, Inc., today reported that revenues for the fourth quarter of 2010 increased 5% to $283.8 million, from $270.3 million for the fourth quarter of 2009. Organic revenue growth, as defined below, was 6%. Earnings per diluted share ("EPS") for the quarter ended December 31, 2010 increased 22% to $0.62, compared to $0.51 for the same period in the prior year.

28 Jan 2011

ACP details challenges facing the U.S. health care system

"The United States is facing an unprecedented crisis in our health care system," reported J. Fred Ralston Jr., president of the American College of Physicians (ACP), at today's annual State of the Nation's Health Care briefing. "We face a crisis in affordable health insurance coverage. We have more uninsured people than ever before. We still are facing a crisis in access to primary care. Health care costs are increasing at rates that the country-and individual families-can't afford."

28 Jan 2011

Tarceva Phase III EURTAC study in NSCLC patients with EGFR activating mutations meets primary endpoint

Genentech, a member of the Roche Group and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., today announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint.

28 Jan 2011

Arena reduces workforce by 25% and provides update on lorcaserin

Arena Pharmaceuticals, Inc. announced today a reduction of its US workforce of approximately 25%, or 66 employees. As a result of the workforce reduction, which Arena plans to complete around March 28, 2011, the company expects to incur restructuring charges, primarily in the first quarter of 2011, of approximately $3.8 million in connection with one-time employee termination costs.

28 Jan 2011

OHC responds positively to Ontario Medical Association pre-election recommendations

The Ontario Health Coalition is responding positively, overall, to the pre-election recommendations made by the Ontario Medical Association.

28 Jan 2011

Gene signature can accurately predict breast cancer outcomes

Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.

28 Jan 2011

Despite reimbursement cuts the diagnostic imaging market to grow at 5% over next five years: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, although the overall diagnostic imaging market has been limited by reimbursement cuts and poor economic conditions, the next five years will see unit growth of approximately 5%.

27 Jan 2011

QIAGEN announces formation of subsidiary in India

QIAGEN today announced the formation of its India subsidiary, QIAGEN India Pvt. Ltd., and the beginning of direct sales in the country. Until now, QIAGEN products have been sold in India through distributor partnerships.

From QIAGEN Manchester Limited 27 Jan 2011

Researchers invent paper microfluidic device for rapid medical diagnostics, chemical analysis

Researchers have invented a technique that uses inexpensive paper to make "microfluidic" devices for rapid medical diagnostics and chemical analysis.

27 Jan 2011

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2010.

27 Jan 2011

Quest Diagnostics releases new data on oral fluid testing system

OraSure Technologies, the market leader in oral fluid diagnostics, announced today that Quest Diagnostics Incorporated released new data indicating that oral fluid revealed approximately five times more heroin use in the general U.S. workforce than previously believed.

From Quest Diagnostics 27 Jan 2011

Diagnostic News and Research

FDA approves Boston Scientific's Renegade HI-FLO Fathom Pre-Loaded System

Radia announces diagnostic imaging services partnership with Jefferson Healthcare

Loyola inaugurates clinic exclusively to treat children with headaches

Research findings could help psychiatrists better diagnose depression, schizophrenia

GE Capital provides capital to XDx to help increase commercialization of AlloMap molecular diagnostic test

FDA reports possible association between breast implants, ALCL

Disparities in limb salvage procedures may be driven by SES, access to high-volume hospitals

New research shows CEUS can improve diagnosis of variety of medical conditions in children

XDx establishes $12.5 million multi-draw term loan facility with GE Capital

IDEXX Laboratories fourth quarter revenues increase 5% to $283.8 million

ACP details challenges facing the U.S. health care system

Tarceva Phase III EURTAC study in NSCLC patients with EGFR activating mutations meets primary endpoint

Arena reduces workforce by 25% and provides update on lorcaserin

OHC responds positively to Ontario Medical Association pre-election recommendations

Gene signature can accurately predict breast cancer outcomes

Despite reimbursement cuts the diagnostic imaging market to grow at 5% over next five years: MRG

QIAGEN announces formation of subsidiary in India

Researchers invent paper microfluidic device for rapid medical diagnostics, chemical analysis

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Quest Diagnostics releases new data on oral fluid testing system

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News